PF-Atlas › Clinical Trials › NCT07132918
HEARTS Trial for Thoracic Cancers
MRgART · Phase 2
Registry ID
NCT07132918
Phase
Phase 2
Status
Recruiting
Drug / intervention
MRgART
Sponsor
University of Wisconsin, Madison
Start
2025-10-08
Enrollment
60
Locations
1
About this trial
The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear accelerator (LINAC) radiation treatment in people with cancer in the thoracic region near the heart. The main question it aims to answer is whether MRgART affects the heart differently than LINAC. Participants will: * Receive radiation therapy * Undergo MRIs and bloodwork * Complete quality of life questionnaires
Explore related
Medical disclaimer. This page summarizes public trial data for NCT07132918 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.